Study to Evaluate Safety, Tolerability, Pharmacokinetics, Pharmacodynamics and Efficacy of ZX-8177 in Patients With Advanced Solid Tumors

NCT07310134 · clinicaltrials.gov ↗
PHASE1
Phase
RECRUITING
Status
80
Enrollment
INDUSTRY
Sponsor class

Conditions

Interventions

Sponsor

Nanjing Zenshine Pharmaceuticals